Differentiation Induction of a Cell Line with a Monoclonal Antibody
Differentiation Induction of a Cell Line with a Monoclonal Antibody
批准号:
03807040
负责人:
KOHNO Nobuoki
金额:
$1.15万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1993
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We studied the differentiation-induction of a breast cancer cell line, YMB-S, from the aspects of growth suppression and acquired cell adhesiveness.Molecules concerned with the adhesiveness were alpha3, alpha5, alphav and beta1 integrins, and E-cadherin. The expression levels of these adhesion molecules were significantly increased in the cells treated with sodium butyrate (NaB) compared with the non-treated cells. E-cadherin and alpha3beta1 integrin localized in the site of cell-cell adhesion. Other integrins and extracellular matrix such as fibronectin, laminin and collagens existed diffusely on cell surface.Differentiation inducers such as 5-azacytidine, n-butyric acid and hexamethylene bisacetamide as well as NaB, dimethyl sulfoxide and dimethylformamide induced differentiation of YMB-S cells. Cycloheximide and actinomycin D suppressed partially the differentiation inducing effects of these differentiation inducers, while each of them alone had similar effects on the cells. These observations indicate that YMB-S cells require both syntheses and synthesis inhibition of protein and/or mRNA to differentiate.It was proven that KL-6 antibody recognizes human MUC-1 mucin (The 3rd IASLC International Workshop on Lung Tumor and Differentiation Antigens. In Zurich. September 9-11,1993). Similar to NaB, KL-6 antibody induced the adhesion of YMB-S cells and inhibited the growth to induce the cells into G0/G1 phase of cell cycle. In vivo effects of KL-6 antibody were tested on the growth of YMB-S cells. Twenty million cells of YMB-S were inoculated subcutaneously into a nude mouse, KL-6 antibody (1 mg) was i.p.injected 14 times in the duration of 7weeks. KL-6 antibody inhibited significantly the growth of the innoculated YMB-S cells compared with a control murine monoclonal antibody (p<0.05, 10mice in each group).
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
H.Hamada, N.Kohno, K.Hiwada: "A new serum tumor marker, CAM 123-6, highly specific to pulmonary adenocarcinoma." Jpn.J.Cancer Res.85. 211-219 (1994)
H.Hamada、N.Kohno、K.Hiwada:“一种新的血清肿瘤标志物 CAM 123-6,对肺腺癌具有高度特异性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
N.Kohno, Y.Inoue, H.Hamada, S.Fujioka, S.Fujino, A.Yokoyama, K.Hiwada, N.Ueda, M.Akiyama.: "Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9." Int.J.Cancer. Supplement, (in press). (1994)
N.Kohno、Y.Inoue、H.Hamada、S.Fujioka、S.Fujino、A.Yokoyama、K.Hiwada、N.Ueda、M.Akiyama.:“KL-6 相关血清诊断值的差异
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
N.Kohno et al.: "Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9" International Journal of Cancer. (1994)
N.Kohno 等人:“分类为第 9 簇的 KL-6 相关粘蛋白之间血清诊断值的差异”国际癌症杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Hamada et al.: "A new serum tumor marker,CAM 123-6,highly specific to pulmonary adenocarcinoma." Japanese Journal of Cancer Research. 85. 211-219 (1994)
H.Hamada 等人:“一种新的血清肿瘤标志物 CAM 123-6,对肺腺癌具有高度特异性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
NOBUOKI KOHNO: "A Circulating heat-nesstant mucin-like antizen in patients with lung ccuncer detected by a new murine monoclonil artibody" International Journal of Onolugy. 1. 649-655 (1992)
NOBUOKI KOHNO:“通过一种新的鼠单克隆抗体检测到肺癌患者的循环耐热粘蛋白样抗原”国际 Onolugy 杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
Anti KL-6 antibody enhances the effects of molecular targeted drug
-
批准号:23659433
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.25万
-
财政年份:2011
-
负责人:KOHNO Nobuoki
-
依托单位:
Comparative studies of a clinical features and genomic analysis in patients with interstitial lung disease and drug induced lung injury
-
批准号:19390224
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.06万
-
财政年份:2007
-
负责人:KOHNO Nobuoki
-
依托单位:
The Study on KL-6 as Morbidity Ornamentation Factor and Prognosis Factor of Idiopathic Interstitial Pneumonia.
-
批准号:14370197
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.83万
-
财政年份:2002
-
负责人:KOHNO Nobuoki
-
依托单位:
The Establishment of KL-6 Associated New Serum Markers Using High Sensitive Electrochemiluminescence Immunoassay.
-
批准号:13557051
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.02万
-
财政年份:2001
-
负责人:KOHNO Nobuoki
-
依托单位:
DEVELOPMENT OF A LUNG CANCER TREATMENT USING ANTI-KL-6/MUC1 MULTI-MONOCLONAL ANTIBODIES
-
批准号:10670548
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1998
-
负责人:KOHNO Nobuoki
-
依托单位:
Clinical Significance of Anti-MUC1 Natural Autoantibody in Sera from Patients with Lung Cancer
-
批准号:08670665
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:KOHNO Nobuoki
-
依托单位:
Screening of new KL-6-associated mucins useful in clinical diagnosis of interstitial pneumonitis
-
批准号:06670618
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1994
-
负责人:KOHNO Nobuoki
-
依托单位:
海外基金